Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha (Q28584176)

From Wikidata

Jump to navigation Jump to search

scientific journal article

Language	Label	Description	Also known as
English	Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha	scientific journal article

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha (English)

1 reference

PubMed publication ID

31 January 2017

1 reference

based on heuristic

inferred from title

author name string

Xian-sheng Huang

1

1 reference

PubMed publication ID

31 January 2017

Shui-ping Zhao

2

1 reference

PubMed publication ID

31 January 2017

Lin Bai

3

1 reference

PubMed publication ID

31 January 2017

Min Hu

4

1 reference

PubMed publication ID

31 January 2017

Wang Zhao

5

1 reference

PubMed publication ID

31 January 2017

Qian Zhang

6

1 reference

PubMed publication ID

31 January 2017

language of work or name

0 references

publication date

1 October 2009

1 reference

PubMed publication ID

31 January 2017

British Journal of Pharmacology

1 reference

PubMed publication ID

31 January 2017

158

1 reference

PubMed publication ID

31 January 2017

3

1 reference

PubMed publication ID

31 January 2017

706–712

1 reference

PubMed publication ID

31 January 2017

Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

17 March 2017

New lipid-lowering agents acting on LDL receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

29 September 2017

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2765591

29 September 2017

Plasma triglyceride level and mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Peroxisome Proliferator-Activated Receptors Mediate Pleiotropic Actions of Statins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2009.00350.X

21 January 2018

Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/19694729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19694729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1476-5381.2009.00350.X

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28584176&oldid=1403932820"